Slover Peter T. - 30 Jan 2026 Form 4 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Role
Chief Financial Officer
Signature
/s/ Peter Slover
Issuer symbol
CTNM
Transactions as of
30 Jan 2026
Net transactions value
$0
Form type
4
Filing time
30 Jan 2026, 16:57:46 UTC
Previous filing
31 Jan 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Slover Peter T Chief Financial Officer 3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO /s/ Peter Slover 30 Jan 2026 0001468012

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTNM Stock Option (right to buy) Award $0 +192,000 $0.000000 192,000 30 Jan 2026 Class A Common Stock 192,000 $14.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted under the Issuer's 2024 Equity Incentive Plan. The options shares vest in equal monthly installments over 48 months, subject to the Reporting Person's continuous service.